A method is described for the preparation of transforming DNA from 1 ml. samples of pneumococcal cultures of low density (e.g. about 10' bacteria). It seemed likely that the precipitation of very small amounts of transforming DNA from lysates of dilute pneumococcus cultures might result in loss of DNA unless a suitable co-precipitant was added. With high dilutions of transforming DNA, it was confirmed that such a loss was obtained. This loss was largely prevented by the addition of sodium hyaluronate in the presence of citrate. Dextran was not as efficient as hyaluronate as a co-precipitant.
INTRODUCTION
The study of certain reactions in bacterial transformation involves the use of lysates of relatively small numbers of bacteria as the source of the transforming DNA. It may sometimes be sufficient for a sample of the culture to be lysed with deoxycholate and used without further purification (e.g. Voll & Goodgall, 1961) , but in some cases it may be desirable to remove substances present in the culture fluid before the lysates are assayed for transforming activity. When the lysates are prepared from 1 ml. samples of suspension containing perhaps not more than lo7 bacteria, simple centrifugation before lysis might involve the risk of loss of some organisms. Hence, a precipitation method is indicated. Fox & Hotchkiss (1960) lysed the bacteria with deoxycholate followed by precipitation with 1-3 vol. of ethanol, centrifugation, and re-solution of the pellet. However, with such small numbers of bacteria the precipitation and recovery of DNA might be incomplete unless a carrier be added. Dr Harriet Ephrussi-Taylor (personal communication) has found that type-specific pneumococcal polysaccharide can act as a suitable coprecipitant with pneumococcal DNA, but its unavailability makes it unsuitable for general use. It was, therefore, decided to test sodium hyaluronate as a co-precipitant, and the results obtained are reported here.
METHODS
Organisms. Streptococcus pneumoniae (213, the receptor organism sensitive to streptomycin; S . pneumoniae r,SQ, derived from C13 but resistant to streptomycin, optochin and erythromycin at the ery-r, level (Ravin & Iyer, 1961) . Both strains * Present address.
were maintained in medium as described by Martin & Ephrussi-Taylor (1964) ,with the addition of defibrinated rabbit blood to 2 % (v/v).
DNA.
Prepared from a lysate of a culture of Streptococcus pneumoniae strain r,SQ made by incubating with 0-6 % (w/v) sodium deoxycholate at 37" for 30 min, Crude DNA was precipitated by 2 vol. ethanol in the presence of citrate, most of the fibrous precipitate obtained being collected by winding on to a glass rod and the rest by centrifuging after decanting most of the mother liquor. A citrate + saline solution of the precipitate was deproteinized by repeated shaking with 0.33 vol. chloroform and 0.1 vol. capryl alcohol followed by final precipitation with 2 vol. ethanol. The DNA threads were wound immediately on to a glass rod and dissolved in sterile O.l5~-NaC1. The concentration of the DNA solution was not determined, but from the experience obtained with previous preparations it was estimated that it was of the order 50-1OOpg. DNA/ml.
Sodium hyaluronate solution. Sodium hyaluronate (Grade 1 , Sigma Chemical
Co., St Louis, Mo., U.S.A.) was dissolved in O-l5~-NaC1 to concentrations of 0.5 and 2.0 mg./ml.
Dextran solution.
Dextran powder (Glaxo Laboratories Ltd., Greenford, Middlesex, England ; Clinical/Technical Grade), having 46 yo of molecular weight between 51,000 and 150,000, was dissolved in O-lS~-Nacl to 20 mg./ml.
Assay of transforming activity.
A ' preculture ' of competent receptor bacteria was obtained by inoculating 0.25 ml. of the stock Streptococcus pneurnoniae strain Cl3
Difco yeast extract, 0.025 % (w/v) glucose, pH 7*6), and incubating at 37" for 24 hr.
From this a competent culture was obtained by inoculating 0.4 ml. preculture into 10 ml. 'NS ' medium (1 % (w/v) charcoal-absorbed Difco Neopeptone, 0.8 % (w/v) charcoal-absorbed Difco yeast extract, 0-025 % (w/v) glucose, containing CaCl, and a fresh extract of yeast as required), plus 0.1-0.2 % (w/v) crystalline bovine albumin, and incubating at 37" until competence appeared. In some cases the preculture was frozen at -70" (in the presence of loyo, v/v, glycerol) and stored at this temperature in 0.5 ml. lots. When required, a 0-5 ml. sample was rapidly thawed and used for the preparation of the competence culture. Fifteen minutes before competence was expected, the culture was cooled in ice and 1 ml. samples added to 5pl. or 10~1. samples of DNA solution and the mixture incubated at 37" for 30min. Suitable dilutions were plated in triplicate in a nutrient agar medium containing blood and incubated for 2 hr to allow expression of the gene conferring streptomycin resistance. At the end of this time, the plates were overlayered with nutrient agar containing streptomycin to give a final concentration in the plate of 200pg. streptomycinlml. The colonies grown on the plates after a further 24~48 hr incubation at 37" were counted, and the average of the triplicate platings calculated. Since there is no mutation to streptomycin resistance at this level, no control plates were necessary. Co-precipitation of DNA. A suitable dilution of DNA in 1 ml. samples was mixed with various amounts of hyaluronate with or without sodium citrate to 0 . 1 5~citrate in conical centrifuge tubes. The mixtures were cooled in ice, 2 vol. ethanol added and shaken to ensure good mixing. The tubes were then allowed to stand in ice for 1 hr. to allow flocculation of precipitate, and centrifuged. The supernatant fluids were decanted, and the tubes allowed to stand inverted on an absorbent tissue for 1 hr. When possible excess liquid was wiped from the inside of the tubes with absorbent tissue, and 1 ml. 0*15~-NaC1 or 1 ml. of a mixture of 1 vol. 0.15~-NaCl + 1 vol. 0.3~-citrate added. The precipitates were loosened from the walls of the tube by shaking, and left to dissolve at 4" for 24 and 48 hr. The DNA solutions were then assayed for their transforming activity and compared with a sample of the original dilution of DNA which had not been processed. The results obtained are shown in Table 2 . It can be seen that without citrate there was a diminution of the transforming activity, whereas with citrate the recovery of even minute amounts of * As in Table 1. DNA was about 85% of the original activity. This figure compares well with that obtained in the presence of hyaluronate but without the precipitation of the DNA. Therefore, no loss was obtained as a result of the precipitation. It can also be seen that there was no advantage obtained by keeping the dissolved precipitates frozen between the first and second day.
RESULTS

Eflect
Comparison was made of the recovery of transforming activity after precipitation with (a) hyaluronate, (b) dextran as co-precipitant, ( c ) no co-precipitant. In all three cases citrate was added. The systems (b) and ( c ) had to be modified. The dextran had to be about ten times more concentrated than hyaluronate before a good precipitate was obtained, and more ethanol was required. Also, after centrifuging, a further period of cooling in ice was desirable before decantation, since the refractive index of the precipitate appeared to change and the precipitate could not be seen unless kept a t 0'. It was also found that in the case of systems (b) and (c) and with this concentration of citrate, a small amount of an immiscible liquid was formed when the ethanol was added. The volume of ethanol added was critical. In absence of co-precipitant, the amount of ethanol had to be decreased to 1.4 vol., and with dextran, the maximum permissible was 2.8 vol. The results are given in Table 3 .
It can be seen that in the absence of co-precipitant there was only 50 % recovery of activity; with the dextran system there was better recovery but much less than with h yaluronat e. Application to Zysates. It was required to prepare DNA for the assay of transforming activity from samples of not more than 1 ml. of bacterial cultures of pneumococci having about 107 organisms/ml. On the basis of the above findings, the procedure adopted was as follows. To 1 ml. of the coccal suspension in a conical centrifuge tube was added 1.0 ml. 0.3~-sodium citrate and 0.1 ml. 5 % (w/v) sodium deoxycholate. The cocci were allowed to lyse for 30-40 min. at 37'. To the lysates were added 2.0 ml. sodium hyaluronate solution (containing 2.0 mg. sodium hyaluronate/ml.), followed by 8-0 ml. (i.e. 2 vol.) ethanol. After mixing, the tubes were allowed to stand in ice for 1 hr, centrifuged and the supernatant liquid decanted. The tubes were stood inverted at room temperature for 1 hr and excess fluid removed by careful wiping with absorbent tissue. The precipitate was dissolved in 1 ml. of a solution containing equal volumes of 0-15~-NaC1 and 0 . 3~citrate. To allow complete solution, the activity of the DNA was not usually assayed before 40 hr.
DISCUSSION
The results recorded in Table 3 confirmed that precipitation of very small amounts of DNA without a co-precipitant might lead to a substantial loss. In the case of a bacterial lysate the bacterial protein may act as a co-precipitant, but its efficiency would probably depend on the number of organisms present and thus vary. It is obviously desirable to provide a co-precipitant at a known concentration; sodium hyaluronate is adequate for this purpose. The deterioration of the transforming activity observed in the earlier experiments was presumably due to contamination of the hyaluronate used with DNase, since it was stopped by adding citrate. In some experiments (not reported here) with a crude preparation of RNA as co-precipitant, low activities were also obtained although the volume of precipitate was satisfactory. This system was not investigated further, but it seems likely that the RNA used was also contaminated with DNase. Different samples of hyaluronate may contain different amounts of DNase, but the use of citrate will protect the DNA from this enzyme. It is, of course, necessary to have a DNase inhibitor present when the bacteria are lysed, to protect the DNA from the endogenous DNase.
Although it was not tested, there is no reason to suppose that this procedure would not be suitable for fewer bacteria but with very large numbers it may not be necessary to add the co-precipitant.
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